Related Experiment Video

Updated: Jan 29, 2026

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
10:39

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity

Published on: June 25, 2015

13.2K

Influenza Vaccines: Good, but We Can Do Better

Catharine I Paules1, Anthony S Fauci2

  • 1Milton S. Hershey Medical Center, Penn State College of Medicine, Hershey, Pennsylvania.

The Journal of Infectious Diseases
|February 5, 2019
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Measuring Influenza Neutralizing Antibody Responses to AH3N2 Viruses in Human Sera by Microneutralization Assays Using MDCK-SIAT1 Cells
12:09

Measuring Influenza Neutralizing Antibody Responses to AH3N2 Viruses in Human Sera by Microneutralization Assays Using MDCK-SIAT1 Cells

Published on: November 22, 2017

18.8K
Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

22.8K

Related Experiment Videos

Last Updated: Jan 29, 2026

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
10:39

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity

Published on: June 25, 2015

13.2K
Measuring Influenza Neutralizing Antibody Responses to AH3N2 Viruses in Human Sera by Microneutralization Assays Using MDCK-SIAT1 Cells
12:09

Measuring Influenza Neutralizing Antibody Responses to AH3N2 Viruses in Human Sera by Microneutralization Assays Using MDCK-SIAT1 Cells

Published on: November 22, 2017

18.8K
Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

22.8K

Related Concept Videos

Vaccinations01:51

Vaccinations

51.7K
Overview
51.7K
Cancer Vaccines01:30

Cancer Vaccines

1.0K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.0K

Articles linked to this work by shared authors, journal, and citation graph.

Transplant Infectious Diseases Work Standards-Results From a Mid-Atlantic Regional Survey.

Transplant infectious disease : an official journal of the Transplantation Society·2026

Target Trial Emulation of Vaccine Effectiveness in 5- to 17-years-olds with Prior SARS-CoV-2 Infection.

Nature communications·2026

Analyzing Real-World Infection Risk in Multiple Myeloma Patients Receiving Teclistamab.

Current oncology (Toronto, Ont.)·2026

Treatment and prevention of HIV/AIDS: Unfinished business.

PLoS medicine·2025

Dose-dependent impact of tixagevimab-cilgavimab as primary prevention against SARS-CoV-2 in immunocompromised individuals.

Scientific reports·2025

Reflection on the Legacy of Lawrence Gostin in Global Health.

The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics·2025

Effect of inactivated poliovirus vaccine on nasal mucosal immunity and pharyngeal shedding following novel oral poliovirus vaccine type 2 challenge: A randomized, open-label trial.

The Journal of infectious diseases·2026

An Observational Study of Vaginal Antibacterial Activity and Outcomes after Antibiotic Prescription for Bacterial Vaginosis.

The Journal of infectious diseases·2026

Chlamydia trachomatis incidence in relation to vaginal microbiota dynamics, immunogenetics and exposures in a cohort of young student women in France.

The Journal of infectious diseases·2026

Low-Level Viremia and Spatial Heterogeneity Among Individuals on Dolutegravir-Based Antiretroviral Therapy in Botswana: A Nationwide Study (2016-2022).

The Journal of infectious diseases·2026

Preferential Reservoir Seeding in HPV16-Specific CD4-T-Cells During HIV-1 Acute and Chronic Infection.

The Journal of infectious diseases·2026

Frailty as a framework to understand tuberculosis severity, recovery and sequelae.

The Journal of infectious diseases·2026

Sex differences in innate immune cell responses: Impact on cancer immunity and response to therapy.

Frontiers in immunology·2026

Vγ9Vδ2 T cells in tuberculosis: protective immunity and translational perspectives.

Frontiers in immunology·2026

The epigenetic-immune-microbiome axis in early life: reprogramming the origins and endotypes of pediatric asthma.

Frontiers in immunology·2026

Spatial architecture of atherosclerotic plaques: coordinating immune responses through mechanotransduction and vesicular trafficking.

Frontiers in cell and developmental biology·2026

Admission CD4+ T cell BTLA expression and its association with infection risk and respiratory outcomes in sepsis.

Frontiers in cellular and infection microbiology·2026

Neuro-immune dysregulation after traumatic brain injury: immunomodulatory strategies to prevent infectious complications.

Frontiers in molecular neuroscience·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us